Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes

AIMS/HYPOTHESIS: Individuals with heterozygous activating mutations of the KCNJ11 gene encoding a subunit of the ATP-sensitive potassium channel (KATP) can usually be treated with oral sulfonylurea (SU) pills in lieu of insulin injections. The aim of this study was to test our hypothesis that younge...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetologia
Main Authors: Thurber, Brian W., Carmody, David, Tadie, Elizabeth C., Pastore, Ashley N., Dickens, Jazzmyne T., Wroblewski, Kristen E., Naylor, Rochelle N., Philipson, Louis H., Greeley, Siri Atma W.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4641523/
https://ncbi.nlm.nih.gov/pubmed/25877689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-015-3593-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki